Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesa Laboratories (MLAB) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for Mesa Laboratories (MLAB) over the last 15 years, with Q4 2025 value amounting to $434.8 million.

  • Mesa Laboratories' Liabilities and Shareholders Equity rose 34.64% to $434.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.7 billion, marking a year-over-year decrease of 227.16%. This contributed to the annual value of $433.3 million for FY2025, which is 300.99% down from last year.
  • Latest data reveals that Mesa Laboratories reported Liabilities and Shareholders Equity of $434.8 million as of Q4 2025, which was up 34.64% from $430.4 million recorded in Q3 2025.
  • Mesa Laboratories' 5-year Liabilities and Shareholders Equity high stood at $741.8 million for Q4 2023, and its period low was $430.4 million during Q3 2025.
  • Its 5-year average for Liabilities and Shareholders Equity is $572.5 million, with a median of $610.8 million in 2021.
  • Its Liabilities and Shareholders Equity has fluctuated over the past 5 years, first surged by 4702.11% in 2021, then tumbled by 4157.91% in 2024.
  • Quarter analysis of 5 years shows Mesa Laboratories' Liabilities and Shareholders Equity stood at $721.7 million in 2021, then dropped by 8.14% to $663.0 million in 2022, then grew by 11.88% to $741.8 million in 2023, then plummeted by 41.58% to $433.3 million in 2024, then grew by 0.35% to $434.8 million in 2025.
  • Its last three reported values are $434.8 million in Q4 2025, $430.4 million for Q3 2025, and $435.7 million during Q2 2025.